TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Net Sales | ₹45 Cr | ₹32 Cr | ₹22 Cr |
What is the latest Revenue of TRIDENT LIFELINE ?
Year | Revenue |
---|---|
Mar2024 | ₹45 Cr |
Mar2023 | ₹32 Cr |
Mar2022 | ₹22 Cr |
How is Revenue of TRIDENT LIFELINE Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹45 Cr | 40.82 | |
Mar2023 | ₹32 Cr | 45.59 | |
Mar2022 | ₹22 Cr | - |
Compare Revenue of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹312.3 Cr | -3.8% | -4.5% | 65.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | -3.8% |
-4.5% |
65.8% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses